1-9 of 9
Corynn Kasap
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

HLA-Pan-DP CAR-T Demonstrates Cytotoxicity Against Multiple Hematological Malignancies

Hiroyuki Takamatsu, Emilio Ramos, Bonell Patino-Escobar, Corynn Kasap, Adila Izgutdina, Juwita Werner, Akihito Inagaki, Takeshi Yoroidaka, Fernando Salangsang, Paul Phojanakong, Juan Antonio Camara Serrano, Veronica Steri, Elliot Stieglitz, Masaki Nagato, Satoshi Tatsuno, Arun P Wiita
Journal: Blood
Blood (2024) 144 (Supplement 1): 1038.
https://doi.org/10.1182/blood-2024-193709
Published: 2024
Journal Articles

Discovery and Development of CD70 As a Cellular Therapy Target in High Risk Multiple Myeloma

Corynn Kasap, Adila Izgutdina, Bonell Patino Escobar, Yu-Hsiu Tony Lin, Huimin Geng, Gianina Wicaksono, Daphne Dupere-Richer, Emilio Ramos, Abhilash Barpanda, Anjanaa Vijayanarayanan, Fernando Salangsang, Paul Phojanakong, Juan Antonio Camara Serrano, Veronica Steri, William Karlon, Mala Shanmugam, Lawrence H. Boise, Benjamin G. Barwick, Jonathan D. Licht, Arun P Wiita
Journal: Blood
Blood (2023) 142 (Supplement 1): 465.
https://doi.org/10.1182/blood-2023-182578
Published: 2023
Journal Articles

Structural Surfaceomics Reveals an AML-Specific Conformation of Integrin-β2 As an Immunotherapeutic Target

Kamal Mandal, Gianina Wicaksono, Clinton Yu, Jarrett J Adams, Michael R Hoopmann, William C Temple, Bonell Patino Escobar, Maryna Gorelik, Christian Ihling, Matthew A Nix, Akul Naik, Emilio Ramos, Corynn Kasap, Veronica Steri, Juan Antonio Camara Serrano, Fernando Salangsang, Paul Phojanakong, Melanie McMillan, Victor Gavallos, Andrew D Leavitt, Andrea Sinz, Benjamin J. Huang, Elliot Stieglitz, Catherine Smith, Robert L Moritz, Sachdeva S Sidhu, Lan Huang, Arun P Wiita
Journal: Blood
Blood (2022) 140 (Supplement 1): 867–868.
https://doi.org/10.1182/blood-2022-162697
Published: 2022
Journal Articles

Novel Chromosomal Rearrangements and Sequence Mutations in High-Risk Ph-Like Acute Lymphoblastic Leukemia

Kathryn G. Roberts, PhD, Ryan D Morin, M.Sc., Jinghui Zhang, PhD, Martin Hirst, Ph.D., Richard C. Harvey, PhD, Corynn Kasap, BS, Xiang Chen, PhD, Michael Edmonson, Ph.D., I-Ming Chen, DVM, MS, Neil Shah, MD, PhD, Meenakshi Devidas, PhD, Gregory H. Reaman, MD, Malcolm A. Smith, MD, PhD, Ching-Hon Pui, MD, James R. Downing, MD, Daniela S Gerhard, Ph.D., Cheryl L Willman, MD, Mignon L Loh, MD, Stephen P Hunger, MD, Marco A. Marra, PhD, Charles G Mullighan, MBBS, MD, FRACP, FRCPA, MSc
Journal: Blood
Blood (2011) 118 (21): 67.
https://doi.org/10.1182/blood.V118.21.67.67
Published: 2011
Journal Articles

Single Molecule Real Time (SMRT™) Sequencing Sensitively Detects Polyclonal and Compound BCR-ABL in Patients Who Relapse on Kinase Inhibitor Therapy,

Catherine C. Smith, MD, Michael Brown, PhD, Jason Chin, PhD, Corynn Kasap, BS, Sara Salerno, BS, Lauren E. Damon, Kevin Travers, PhD, Susana Wang, Andrew Kasarskis, PhD, Eric Schadt, PhD, Neil Shah, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3752.
https://doi.org/10.1182/blood.V118.21.3752.3752
Published: 2011
Journal Articles

Preliminary Clinical Activity in a Phase I Trial of the BCR-ABL/IGF- 1R/Aurora Kinase Inhibitor XL228 in Patients with Ph + + Leukemias with Either Failure to Multiple TKI Therapies or with T315I Mutation

Jorge Cortes, MD, Ronald Paquette, MD, Moshe Talpaz, Javier Pinilla, MD, PhD, Ekatherine Asatiani, MD, Meir Wetzler, MD, Jeffrey H. Lipton, MD, PhD, Corynn Kasap, BS, Lynne A. Bui, MD, Douglas O. Clary, PhD, Neil Shah, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 3232.
https://doi.org/10.1182/blood.V112.11.3232.3232
Published: 2008
Journal Articles

Beyond the Gatekeeper: Imatinib- and Dasatinib-Resistant BCR-ABL/F317 Mutations Confer Cross-Resistance to VX-680 but Are Sensitive to a Structural Derivative of VX-680

Corynn Kasap, BS, Nicholas Hertz, B.S., Debora Makino, Ph.D., Kevan Shokat, Ph.D., John Kuriyan, Ph.D., Neil P. Shah, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 725.
https://doi.org/10.1182/blood.V112.11.725.725
Published: 2008
Journal Articles

Targeting Drug-Resistant CML and Ph+-ALL with the Spectrum Selective Protein Kinase Inhibitor XL228.

Neil P. Shah, Corynn Kasap, Ronald Paquette, Jorge Cortes, Javier Pinilla, Moshe Talpaz, Lynne A. Bui, Douglas O. Clary
Journal: Blood
Blood (2007) 110 (11): 474.
https://doi.org/10.1182/blood.V110.11.474.474
Published: 2007
Journal Articles

Optimal Treatment for Patients after Dasatinib or Nilotinib: Comparison of Preclinical Activities of Approved and Promising Investigational Kinase Inhibitors Against BCR-ABL Kinase Domain Mutations That Confer Clinical Resistance to Dasatinib or Nilotinib.

Corynn Kasap, BS, Christopher Weier, BS, Neil P. Shah, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 4589.
https://doi.org/10.1182/blood.V110.11.4589.4589
Published: 2007